Publication | Open Access
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
149
Citations
15
References
2020
Year
Cervical Cancer ManagementPhase Ii EvaluationCervical CancerCervical HealthMedicineCancer ManagementGynecologyRecurrent Cervical CancerCancer TreatmentPublic HealthOncologyRadiation OncologyGynecology Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1